premise: Amdoxovir is a nucleoside reverse transcriptase inhibitor (NRTI) undergoing research for the treatment of HIV/AIDS. It was discovered by Raymond F. Schinazi (Emory University) and C.K. Chu (University of Georgia). It is being developed by RFS Pharma. Currently, it is in Phase II clinical studies.
hypothesis: Amdoxovir is available with a prescription. 
reason: Amdoxovir is still in clinical trials. Is it not yet available to the public with simply a prescription. 